Fast Track Designation
FDA Grants Fast Track Designation for Farxiga in Heart Failure
AstraZeneca
PR-M09-19-NI-042Sep 18, 2019
FDA Approval
FDA Approves New Device to Improve Symptoms in Patients with Advanced Heart Failure
U.S. Food & Drug Administration
PR-M08-19-NI-055Aug 20, 2019
FDA Fast Track
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Eli Lilly and Company
PR-M06-19-NI-058Jun 28, 2019